Ev Biologics

(OTC) YECO

Current Price$0.00

Market Cap$1.40K

Since IPO (2015)-100%

5 Year-100%

1 Year-100%

1 Month-100%

Ev Biologics Financials at a Glance

Market Cap

$1.40K

Revenue (TTM)

$226.36K

Net Income (TTM)

$51.13K

EPS (TTM)

$0.01

P/E Ratio

0.04

Dividend

$0.00

Beta (Volatility)

-0.60 (Low)

Dividend

$0.00

Beta (Volatility)

-0.60 (Low)

Price

$0.00

Volume

51,200

Open

$0.00

Price

$0.00

Volume

51,200

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.11

Estimated Earnings Date

Dec 31, 2017

Dividend

$0.00

Beta (Volatility)

-0.60 (Low)

Price

$0.00

Volume

51,200

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.11

Estimated Earnings Date

Dec 31, 2017

YECO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ev Biologics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Daniel S. McKinney, CPA

Website

www.yulongecomaterials.com

Headquarters

Cheyenne, WY 82001, US

YECO Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

-39%

Net Income Margin

-39%

Return on Equity

Return on Capital

Return on Assets

-7%

Earnings Yield

25.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.40K

Shares Outstanding

7.23M

Volume

51.20K

Avg. Volume

2.78K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$298.57K

EBITDA

-$298.57K

Operating Cash Flow

-$126.49K

Capital Expenditure

$2.00

Free Cash Flow

-$126.49K

Cash & ST Invst.

$16.00

Total Debt

$1.50M

Ev Biologics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$1.40K

N/A

Market Cap/Employee

$4.93

N/A

Employees

284

N/A

Net Income

-$46.52K

+75.7%

EBITDA

-$46.52K

+75.7%

Quarterly Fundamentals

Name

Q2 2025YOY CHG

Total Cash

$16.00

-99.6%

Total Debt

$1.50M

+0.2%

Accounts Receivable

$435.79K

+68.7%

Inventory

$0.00

N/A

Long Term Debt

$1.50M

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-7.21%

N/A

Return on Invested Capital

6.11%

N/A

Free Cash Flow

$370.00

-100.0%

Operating Cash Flow

$369.02

-100.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TRLFFMaven Brands Inc.

TRLFFMaven Brands Inc.$0.00+0.00%

BNGIBangi Inc.

BNGIBangi Inc.$0.00+0.00%

VPROViropro Inc.

VPROViropro Inc.$0.00+0.00%

BPTSYBiophytis S.A.

BPTSYBiophytis S.A.$0.25+0.00%

SQZBSQZ Biotechnologies Company

SQZBSQZ Biotechnologies Company$0.02+0.00%

EMMAEmmaus Life Sciences, Inc.

EMMAEmmaus Life Sciences, Inc.$0.01-6.36%

BIEIPremier Biomedical, Inc.

BIEIPremier Biomedical, Inc.$0.00-7.69%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

TSLATesla

TSLATesla$406.43+0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

ONDSOndas

ONDSOndas$9.33-0.05%

Questions About YECO

What is the current price of Ev Biologics?

Ev Biologics is trading at $0.00 per share.

What is the 52-week range for Ev Biologics?

Over the past 52 weeks, Ev Biologics has traded between $0.00 and $0.11.

How much debt does Ev Biologics have?

As of the most recent reporting period, Ev Biologics reported total debt of $1.50M.

How much cash does Ev Biologics have on hand?

Ev Biologics reported $116.00 in cash and cash equivalents in its most recent financial results.

What is Ev Biologics’s dividend yield?

Ev Biologics does not currently have a dividend yield.

Ev Biologics

Ev Biologics Financials at a Glance

YECO News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Ev Biologics

YECO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Ev Biologics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About YECO

What is the current price of Ev Biologics?

What is the 52-week range for Ev Biologics?

How much debt does Ev Biologics have?

How much cash does Ev Biologics have on hand?

What is Ev Biologics’s dividend yield?

Premium Investing Services